TLR4 and malignant colon neoplasm: LY96 interacted with TLR4 and activated the nuclear factor-κB (NF-κB) pathway, and thereby promoted the production of pro-inflammatory cytokines and adhesive molecules in colon cancer cells, which accelerate colon cancer growth and lung metastasis (Rajamanickam et al., 2020).